[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100495992":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":12,"centralContacts":25,"locations":34,"responsibleParty":51,"collaborators":12,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":12,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":12,"enrollmentInfo":63,"targetDuration":12,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":36,"whyStopped":12,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"University of Vermont Medical Center","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Control: Usual Care","NO_INTERVENTION","will receive standard treatment which entails referral to Vermont Quit Network. This network offers a wide range of free cessation services, including NRT and web-based modules on preparing to quit and developing a plan",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Intervention: Financial incentives and nicotine replacement therapy intervention","EXPERIMENTAL","an intervention where patients are assigned to financial incentives and NRT of their choice; use of CO monitor to assess abstinence",[18],"Behavioral: Financial Incentives (FI) and Nicotine Replacement Therapy (NRT)",[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":12},"BEHAVIORAL","Financial Incentives (FI) and Nicotine Replacement Therapy (NRT)",": In the intervention condition, patients will receive both NRT plus a 12-week program of monetary incentives for verified smoking abstinence that will be implemented by our clinic staff",[14],[26,31],{"name":27,"role":28,"phone":29,"phoneExt":12,"email":30},"Sherrie Khadanga, MD","CONTACT","802-847-2700","sherrie.khadanga@uvmhealth.org",{"name":32,"role":28,"phone":12,"phoneExt":12,"email":33},"Diann Gaalema, PhD","diann.gaalema@med.uvm.edu",[35],{"facility":5,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Burlington","Vermont","05405","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-73.21207,44.47588,{"lat":46,"lon":45},[49],{"name":50,"role":28,"phone":29,"phoneExt":12,"email":30},"Sherrie Khadanga",{"type":52,"investigatorFullName":50,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"PRINCIPAL_INVESTIGATOR","PI","100495992","remote-smoking-cessation-in-hospitalized-cardiac-patients-100495992",false,"NCT05738408","Remote Smoking Cessation in Hospitalized Cardiac Patients","Remote Smoking Cessation in Hospitalized Cardiac Patients: Bridging the Post-discharge","Inclusion Criteria:\n\nPatients will be recruited if they:\n\n1. Hospitalization for an acute coronary event which includes myocardial infarction or coronary revascularization (percutaneous intervention or coronary artery bypass)\n2. live within 30 miles of UVMMC and are \\>18 years of age\n3. Current cigarette smoker (defined as reporting any use of cigarettes in the week before admission and \\>5 cigarette\u002Fday on average over the past 3 months)\n\nExclusion Criteria:\n\nPatients will be excluded if they have:\n\n1. severe dementia\u002FAlzheimer's disease\n2. an active malignancy, excluding non-melanoma skin cancer or low-grade prostate cancer under active surveillance\n3. exercise limiting vascular or neuromuscular disease\n4. Non-English Speaking\n5. No reliable smart-phone\n6. Current, regular use of smokeless tobacco or other form of non-combusted tobacco","ALL","18 Years",{"count":64,"type":65},50,"ESTIMATED","INTERVENTIONAL",[68],"NA","The investigators are proposing to examine new strategies for helping patients hospitalized for an acute coronary event adhere to recommendations to quit smoking. The investigators are interested to see whether offering financial incentives for smoking cessation, combined with medications to ameliorate withdrawal, can significantly reduce smoking in a population for which continued smoking has disproportionately negative health effects. The proposed trial can provide significant knowledge for promoting adherence to smoking cessation guidelines in patients with cardiac disease",[71],"Smoking Cessation",[73,74],"smoking cessation","secondary prevention","2025-01-16",{"date":77,"type":78},"2025-01-20","ACTUAL",{"date":80,"type":78},"2022-08-12",{"date":82,"type":65},"2025-12",{"name":5,"class":6},1]